Evaluating the Impact of <scp>CYP1A2</scp> Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study
- DOI
- 10.1002/prp2.70321
- Published
- 2026-09-22
- Container
- Pharmacology Research & Perspectives
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/prp2.70321,
title = {Evaluating the Impact of
<scp>CYP1A2</scp>
Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study},
author = {Kowser Miah and Jitendar Reddy and Pradeep Sharma and Ike Igwegbe and Simon Nelson and Caitlin Muldoon and Ronald Goldwater and Karthick Vishwanathan},
year = {2026},
journal = {Pharmacology Research \& Perspectives},
doi = {10.1002/prp2.70321},
url = {https://doi.org/10.1002/prp2.70321}
}RIS
TY - JOUR
TI - Evaluating the Impact of
<scp>CYP1A2</scp>
Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study
AU - Kowser Miah
AU - Jitendar Reddy
AU - Pradeep Sharma
AU - Ike Igwegbe
AU - Simon Nelson
AU - Caitlin Muldoon
AU - Ronald Goldwater
AU - Karthick Vishwanathan
PY - 2026
JO - Pharmacology Research & Perspectives
DO - 10.1002/prp2.70321
UR - https://doi.org/10.1002/prp2.70321
ER - APA
Miah, K., Reddy, J., Sharma, P., Igwegbe, I., Nelson, S., Muldoon, C., Goldwater, R., & Vishwanathan, K. (2026). Evaluating the Impact of <scp>CYP1A2</scp> Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70321
Source records
- crossref · retrieved 2026-09-24T21:35:37.036Z